Bayer

One of the largest SPACs seeking a target could be nearing a $20 billion deal to bring one of the largest privately-held biotechnology companies public. The SPAC Rumor: Bloomberg reports Ginkgo Bioworks is in talks with Soaring Eagle Acquisition Corp (NASDAQ: SRNGU), a SPAC led by Harry Sloan and...

Germany drugmaker Bayer's acquisition of Monsanto closed this week after a challenging two-year-long review process. Despite creating the world's largest seed and agricultural chemicals maker, the "highly competitive environment" will remain unchanged, Bayer CEO Werner...

The U.S. Department of Justice's move to approve German pharma company Bayer AG's acquisition of U.S.-based Monsanto Company (NYSE: MON) prompted at least one Wall Street analyst to turn bearish on the stock. The Analyst Argus' Bill Selesky downgraded Monsanto's stock rating...

Susquehanna analyst Don Carson downgraded Monsanto Company (NYSE: MON) from Positive to Neutral, while raising its price target from $125 to $128. The downgrade is not a result of increasing headwinds or poor performance, but rather because the 9-percent upside from Bayer AG (ADR) (OTC: BAYRY)'s $...

Monsanto Company (NYSE: MON) disclosed Tuesday that its Board has unanimously rejected Bayer AG's revised proposal. The company termed it as financially inadequate and insufficient to ensure the deal certainty. However, Monsanto indicated its willingness to remain open to continued, as well...

Monsanto Company (NYSE: MON) confirmed Thursday that it received a revised, non-binding proposal from Bayer AG for a possible acquisition of the company. The company indicated that its Board would review the proposal, in consultation with its financial and legal advisors. The company disclosed...

Shares of Monsanto Company (NYSE: MON) were trading higher by more than 5 percent on Monday at $107.24 after Bayer made public its intentions to acquire the company for $122 per share. Given the notable discount in Monsanto's trading price to the takeout offer, investors and traders could...

Germany-based Bayer publicly disclosed Monday morning details of its proposed acquisition of Monsanto Company (NYSE: MON) following market speculation and stakeholder inquiries last week. Pricing Bayer confirmed it has made an all-cash offer to acquire all of Monsanto's common stock for $122 per...

Citi’s P.J. Juvekar believes the acquisition of Monsanto Company (NYSE: MON) by Bayer is unlikely to occur, given the potential synergies, divestitures needed, regulatory concerns and more. Juvekar maintains a Neutral rating on Monsanto, with a price target of $94. Synergies The analyst...

Shares of Monsanto Company (NYSE: MON) surged higher by more than 17 percent early Thursday morning after the company was named as a potential takeover target. Street Insider, citing "sources claiming to have knowledge of the situation," reported Wednesday evening that Germany-based...